|
|
||||||||
GROWTH, DIFFERENTIATION, AND APOPTOSIS
Departments of 1Physiology & Biophysics, 2Pediatrics, and 3Biochemistry & Molecular Biology, University of Arkansas for Medical Sciences, and 4Arkansas Children's Hospital Research Institute, Little Rock, Arkansas; and 5Department of Pediatrics, Shands Children's Hospital, University of Florida, Gainesville, Florida
Submitted 15 January 2003 ; accepted in final form 1 September 2004
Wound healing is a response to injury that is initiated to reconstruct damaged tissue. In skin, reepithelialization involves both epithelial cells and fibroblasts and contributes to the reformation of a barrier between the external environment and internal milieu. Growth factors including epidermal growth factor (EGF) play important roles in promoting this process. In the present studies we employed CV-1 fibroblasts in a tissue culture model of reepithelialization to develop strategies for optimizing wound closure stimulated by EGF. We found that EGF enhanced cell motility within 68 h of EGF treatment in serum-free medium but wounds failed to close within 24 h. However, if medium on these cultures was exchanged for medium containing serum, cells pretreated with EGF closed new scrape wounds more rapidly than did cells that were not pretreated. These results indicate that serum factors work in concert with EGF to coordinate cell motility for efficient wound closure. Indeed, EGF enhanced the rate of wound closure in the presence of serum, and this effect also persisted for at least 24 h after EGF was removed. This coordination of EGF-induced cell motility was accompanied by an increase in the transient phosphorylation of ERK1 and ERK2. The persistent effects of EGF were blocked by transient exposure to reversible inhibitors of transcription and translation, indicating that the expression of new proteins mediated this response. We propose that EGF-stimulated CV-1 fibroblast motility is coordinated by a serum component that induces cell-cell adhesive properties consistent with an epithelial phenotype, thereby enhancing the reepithelialization process.
wound healing; cell motility
This article has been cited by other articles:
![]() |
M. Poujade, E. Grasland-Mongrain, A. Hertzog, J. Jouanneau, P. Chavrier, B. Ladoux, A. Buguin, and P. Silberzan From the Cover: Collective migration of an epithelial monolayer in response to a model wound PNAS, October 9, 2007; 104(41): 15988 - 15993. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Schnackenberg, S. M. Jones, C. Pate, B. Shank, L. Sessions, L. M. Pittman, L. E. Cornett, and R. C. Kurten The beta-agonist isoproterenol attenuates EGF-stimulated wound closure in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L485 - L491. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |